A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.

NCT03636347 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha 1-Antitrypsin Deficiency
Emphysema
COPD

Interventions

DRUG: Placebo Oral Tablet
DRUG: Alvelestat oral tablet - dose 1
DRUG: Alvelestat oral tablet - dose 2

Sponsor

Mereo BioPharma

Collaborators

[object Object]